Atrial Fibrillation Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $8,319 million by 2022, registering a CAGR of 13.0% during the period 2014 - 2022. Non-surgical devices segment dominated the overall market in 2015. North America was the leading geographic segment in global atrial fibrillation devices market in 2015, and is expected to maintain its leading position throughout forecast period. Read more details at: https://www.alliedmarketresearch.com/atrial-fibrillation-market
Ablation is minimal invasion technique which involves removal of malfunctioning tissues either by surgery, chemicals or by radiofrequency. It is used in various treatments such as cancers, atrial fibrillation, cosmetology, and orthopedics, among others.
Atrial Fibrillation (AF) Surgery Market size should witness significant growth due to increased prevalence of atrial fibrillation over the last few years. Rising geriatric population coupled with increased prevalence of heart diseases will drive the global atrial fibrillation surgery market size. It is most commonly occurring dysrhythmia worldwide. An estimated three million adults have diagnosed with the disease in the U.S. with its prevalence expected to reach four million by 2030, and 5.6 million by 2050. Increasing global prevalence of obesity due to sedentary lifestyle, lack of physical activity and unhealthy dietary habits will increase the number of surgeries performed. As per WHO, in 2014, about 13% of adults were obese while 39% were overweight. Obesity leads to various types of cardiac disorders and is the second leading cause of preventable death in the U.S.
Global anticoagulants market size is expected to reach $77.71 Bn by 2028 at a rate of 11.7%, segmented as by drug class, factor xa inhibitor, heparin and lmwh, vitamin k antagonist, other drug classes
The global cardiac pacemakers market is expected to grow from $4.03 billion in 2021 to $4.26 billion in 2022 at a compound annual growth rate (CAGR) of 5.63%.
According to the latest research report by IMARC Group, The global left atrial appendage closure devices market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.3 Billion by 2032, exhibiting a growth rate (CAGR) of 16.85% during 2024-2032. More Info:- https://www.imarcgroup.com/left-atrial-appendage-closure-devices-market
According to the latest research report by IMARC Group, The global left atrial appendage closure devices market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.3 Billion by 2032, exhibiting a growth rate (CAGR) of 16.85% during 2024-2032. More Info:- https://www.imarcgroup.com/left-atrial-appendage-closure-devices-market
The Left Atrial Appendage Market size is estimated to reach $2,247 million by 2027. Furthermore, it is poised to grow at a CAGR of 19.7% over the forecast period of 2022-2027. The left arterial appendage is a small ear-shaped sac found in the muscle wall of the left atrium. When a person isn’t suffering from any major ailments, the blood in the left atrium and LAA is squeezed out of the left atrium into the left ventricle (bottom left chamber of the heart) as and when the heart contracts or beat. However, in cases of atrial fibrillation, the electrical impulses which guide the heart to beat do not follow the right motion or order.
According to the latest research report by IMARC Group, The global anticoagulants market size reached US$ 37.4 Billion in 2022 Looking forward, IMARC Group expects the market to reach US$ 67.0 Billion by 2028, exhibiting a growth rate (CAGR) of 10.1% during 2023-2028. More Info:- https://www.imarcgroup.com/anticoagulants-market
The global emulsifiers market size is expected to reach USD 13.08 Billion at a revenue CAGR of 6.3% in 2028, according to latest analysis by Emergen Research. Rapidly rising demand for convenience and processed foods, increasing oil and gas exploration and production activities, and increasing food demand globally are some key factors driving steady market revenue growth.
According to the latest research report by IMARC Group, The global ablation devices market size reached US$ 5.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2028, exhibiting a growth rate (CAGR) of 11.5% during 2023-2028. More Info:- https://www.imarcgroup.com/ablation-devices-market
Looking forward, the anticoagulants market value is projected to reach a strong growth during the forecast period (2022-2027). More info:- https://www.imarcgroup.com/anticoagulants-market
Research Beam added a report on “Atrial Fibrillation - Pipeline Review, H2 2015” Enquiry about report: http://www.researchbeam.com/atrial-fibrillation-pipeline-review-h2-2015-market/enquire-about-report
Germany held dominant position in Europe gelatin and bone glue market in 2019, accounting for 23.5% share in terms of volume, followed by France and U.K.,respectively
Global Electrophysiology Devices And Equipment Market by The Business Research Company is segmented as Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Lab Systems https://bit.ly/3l7ZKzo
The US ambulatory ECG market is set to experience favorable growth driven by factors such rising ageing population. For more mail: vikas@konceptanalytics.com
Adoption of hectic lifestyle and unhealthy habits like excess consumption of sugar-rich diet, smoking, lack of physical activity and alcoholism cause a number of chronic cardiovascular diseases (CVDs).
Download Sample Brochure @ http://bit.ly/2e9aeL8 DelveInsight’s Diabetic retinopathy - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the disease and global market trends of the %Indication"% for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Diabetic retinopathy forecasted market share for ten years to 2020 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Diabetic retinopathy till 2020. Read Analysis @ http://bit.ly/2dRoh9m
Asia Pacific Electrophysiology (EP) Market Size is estimated to cross USD 2.5 Billion By 2027. Increasing prevalence of cardiac disorders such as atrial fibrillation, atrial flutter and tachycardia among others in the region and launch of new advanced products will influence electrophysiology revenue growth during forecast period. The recent COVID-19 pandemic has negatively impacted the electrophysiology procedures upto some extent. Elective procedures were differed during the initial phase of the outbreak to reduce cross contamination in healthcare settings. However, as COVID-19 cases are declining across the globe, the APAC electrophysiology market will witness gradual growth in the future.
An extensive study of the product application and services conducted by subject matter experts assessing the market will help product owners to make a wise decision.
The global ablation technology market size is expected to reach USD 13.87 Billion in 2032 and register a steady revenue CAGR of 9.3% during the forecast period, according to latest analysis by Emergen Research. Increasing development of advanced technologies and rising availability and accessibility of innovative ablation products are major factors driving market revenue growth.
Strong prevalence and growth in number of patients suffering from cardiovascular diseases, increasing number of hip and knee replacement surgical procedures, growth in atrial fibrillation, and increasing incidences of deep vein thrombosis (DVT) are the key factors fueling growth of the global anticoagulant market. Anticoagulants are used to prevent formation of blood clots by reacting with the clotting chemicals in the blood
growth of the heparin market is driven by rise in prevalence of coronary heart disease and myocardial infection, rise in cases of venous thromboembolism and cardiovascular disorders
Market Size – USD 904.5 Million in 2021, Market Growth – at a CAGR of 7.0%, Market Trends – Growing Research & Development (R&D) activities in the North America region
24 Market Reports provides a complete data analysis of 2017-2022 United States Heparin Sodium Report (Status and Outlook) with Market value, Sales, Price, Industry Analysis and Forecast with the help of Industry Experts.
The global fabric protection market size was USD 2.42 Billion in 2022 and is expected to reach USD 4.7 Billion in 2032, and register a revenue CAGR of 7.6% during the forecast period. Rising demand for hassle-free apparel that is easy to clean and maintain and fabric protection products in recreational activities and adventurous sports Clothing, along with increasing awareness about the harmful effects of chemicals on the environment and human health are major factors driving market revenue growth.
The global cardiovascular pharmaceuticals market is estimated to garner a revenue of USD 234 Billion by the end of 2033 by growing at a CAGR of ~5% over the forecast period, i.e., 2023 – 2033.
The global home healthcare market size was USD 198.78 Billion in 2021 and is expected to register a revenue CAGR of 8.3%, during the forecast period, according to the latest analysis by Emergen Research. Home healthcare market revenue growth is primarily driven by factors such as rising incidence of chronic diseases such as diabetes, cardiovascular disease, and hypertension and increasing technological advancements in-home healthcare products.
The global optically clear adhesives market size is expected to reach USD 3,218.7 Million in 2028 and register a revenue CAGR of 9.2% over the forecast period, according to latest analysis by Emergen Research. Some key factors driving steady market revenue growth include rising demand for touchscreen display devices and optical devices among consumers.
Growing demand for smartphone applications in automobiles and advances in technology for In-Vehicle Infotainment are driving the demand for the market.
North America Electrophysiology Market Size is Estimated To Exceed USD 3.5 Billion By 2027.Novel product launch and growing incidence of several cardiac arrhythmias is set to gradually stimulate electrophysiology market growth. The COVID-19 pandemic has significantly disrupted the healthcare industry up to great extent. It has impacted the business sales of several firms and subsequently the revenue generated through elective and non-emergent procedures. With such impact, the number of electrophysiology procedures conducted in 2020 witnessed considerable downfall and has thereby negatively influenced the overall North America electrophysiology market size. However, with growing incidence of heart rhythm disorders and subsequent deterioration in prevalence of coronavirus infection, the industry is forecasted to recover and gradually grow in the foreseeable future to meet the unmet market demand.
The global endometrial ablation devices market size is expected to reach USD 1,596.9 Million at a steady revenue CAGR of 5.3% in 2028, according to latest analysis by Emergen Research. Steady endometrial ablation devices market revenue growth can be attributed to rising prevalence of gynecological disorders in women, including menorrhagia that are responsible for patients opting for advanced surgical procedures such as endometrial ablation.
Heparin is a glycosaminoglycan that occurs naturally. It is used as an anticoagulant in medicine (blood thinner). It is particularly useful in the treatment of heart attacks and unstable angina. It is injected into a vein or injected under the skin.
Europe Electrophysiology Market Size is Estimated to Surpass USD 3.4 Billion By 2027.A Significant increase in number of patients with cardiac diseases, leading to high risk of heart stroke will influence the electrophysiology revenue growth during forecast period. COVID-19 has impacted the Europe electrophysiology market size during the pandemic period due to reduction procedural volume. Emergence of viral infection hampered product sales of several firms, thereby resulting in declined revenue growth. However, constant organizational efforts and relatively reduced prevalence of COVID-19 in some countries is expected to boost the industry growth over forecast period.
The Global Implantable Loop Recorders Market size is expected to reach $2.1 billion by 2026, rising at a market growth of 11.9% CAGR during the forecast period. The implantable loop recorder (ILR) is a portable cardiac recording system capable of continuously saving ECG data in the case of bradyarrhythmia or tachyarrhythmia. Full Report: https://www.kbvresearch.com/implantable-loop-recorders-market/
Wearable ECG Monitors Market Global Report 2020 is the latest research report added to The Business Research Company database. The report is covered in 150 pages covering 5 major players in the industry.
Global Implantable Cardiac Monitors Market size is expected to reach $682 million by 2023, rising at a market growth of 7.6% CAGR during the forecast period. Full report: https://kbvresearch.com/implantable-cardiac-monitors-market/